What are the features of the anti-Müllerian hormone type II receptor (AMHR2)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Anti-Müllerian Hormone Type II Receptor (AMHR2) Features

AMHR2 is a transmembrane serine/threonine kinase receptor that serves as the dedicated type II receptor for AMH signaling, featuring a unique extracellular binding domain with a three-finger toxin fold and an intracellular kinase domain that activates downstream Smad1/5/8 signaling pathways.

Structural Characteristics

AMHR2 is a member of the transforming growth factor-beta (TGF-β) receptor superfamily with distinct structural features 1, 2:

  • Single transmembrane domain with serine/threonine kinase activity
  • Extracellular domain containing a modified three-finger toxin fold that binds AMH 1
  • Intracellular STYKc kinase domain (approximately 443 amino acids in total protein length) 3
  • Unique binding interface: AMH binds to the concave side of AMHR2's extracellular domain, with critical residues including Asp53 and Ala55 in the DRAQVEM epitopic sequence 4
  • Species-specific variations: The human receptor differs from murine versions at key residues (aspartic acid vs. glycine at position 53), accounting for species-specific antibody recognition 4

Molecular Signaling Mechanisms

AMHR2 mediates AMH signaling through a well-characterized pathway 5, 2:

  • Primary signaling: Engages the Smad1/5/8 pathway as the main downstream effector
  • Type I receptor recruitment: Recruits BMPR-IB (type I receptor) to form the active signaling complex 2
  • Cross-talk pathways: Interacts with Wnt/β-catenin and MAPK cascades to regulate follicular growth and steroidogenesis 5
  • Binding specificity: A salt bridge formed by K534 on AMH and D81/E84 of AMHR2, along with finger 1 conformation, are critical for the AMH/AMHR2 interaction 1

Tissue Expression and Distribution

AMHR2 demonstrates highly specific expression patterns across reproductive tissues 6, 7:

Ovarian Expression

  • Granulosa cells of pre-antral and small antral follicles 7
  • Early-stage oocytes including oogonia and primary oocytes 3
  • Expression persists from birth through the end of ovarian activity 2

Testicular Expression

  • Sertoli cells from fetal sex differentiation through puberty 2
  • Spermatogonia (predominant), with weaker signals in primary spermatocytes 3

Extra-Gonadal Expression

Recent evidence reveals broader distribution 5, 6:

  • Neuronal tissue: Hypothalamic neurons expressing AMHR2 play a critical role in modulating the hypothalamic-pituitary-ovarian (HPO) axis 6
  • Pituitary gland
  • Uterus and placenta: Particularly in interstitial trophoblast cells during early pregnancy 8

Functional Roles

Male Sexual Differentiation

  • Müllerian duct regression: Primary function during male fetal development, causing regression of female reproductive tract precursors 1, 2
  • Gonadal differentiation: Influences testicular development and function 4

Female Reproductive Function

AMHR2 serves multiple context-dependent roles 5, 7:

  • Follicular regulation: Inhibits recruitment of primordial follicles from the resting oocyte pool
  • FSH modulation: Suppresses follicle-stimulating hormone action, contributing to ovulatory control 7
  • Oocyte quality: Influences expression of quality markers (GDF9, BMP15) 6

Neuroendocrine Regulation

Neuronal AMHR2 is the critical mediator of AMH's systemic effects 6:

  • Modulates HPO axis hormone secretion
  • Regulates cyclic follicular development
  • Disruption of neuronal AMH/AMHR2 signaling contributes to PCOS pathogenesis through altered LH, FSH, testosterone, and estrogen levels 6

Placental Function

  • Trophoblast invasion and migration: AMH/AMHR2 signaling enhances trophoblast cell migration and invasion capacity, potentially influencing embryo implantation and placenta formation 8

Clinical Significance

PCOS Biomarker Context

While AMHR2 itself is not used diagnostically, understanding its function is critical because 7:

  • Women with PCOS have significantly elevated serum AMH levels
  • AMH acts through AMHR2 to potentially cause PCOS pathology
  • Neuronal AMHR2 knockout protects against AMH-induced PCOS symptoms, demonstrating the receptor's central role in disease pathogenesis 6

Tumor Marker Applications

  • AMHR2 expression serves as a marker for granulosa and Sertoli cell tumors 4
  • Monoclonal antibodies targeting AMHR2 (such as mAb 12G4) have potential for immunotargeting of receptor-expressing tumors 4

Important Caveats

  • Evolutionary uniqueness: Both AMH and AMHR2 occupy isolated positions in their respective family dendrograms, indicating specialized co-evolution 9
  • Compartmentalized signaling: Extra-ovarian (particularly neuronal) AMHR2 expression has more profound systemic effects on reproductive function than intra-ovarian expression alone 6
  • Species differences: Receptor structure and antibody recognition vary significantly between species, limiting direct translation of animal model findings 4

References

1
Research

Structure of AMH bound to AMHR2 provides insight into a unique signaling pair in the TGF-β family.

Proceedings of the National Academy of Sciences of the United States of America, 2021

2
Research

Anti-Müllerian hormone and its receptors.

Molecular and cellular endocrinology, 2001

7
Guideline

anti-müllerian hormone in pcos: a review informing international guidelines.

Trends in Endocrinology and Metabolism, 2019

9
Research

Welcome to the family: the anti-müllerian hormone receptor.

Molecular and cellular endocrinology, 1994

Related Questions

What oral medication is appropriate for a male patient with normal laboratory results who has abdominal bloating?
What is the definition of myasthenic crisis?
What is the appropriate dosing regimen of Keflex (cefalexin) for this patient?
Should I obtain a culture for a weeping wound?
Given that my recent rheumatology visit showed five complete blood counts and five comprehensive metabolic panels all within normal limits, with creatinine values ranging from 1.12 to 1.33 mg/dL and estimated glomerular filtration rate consistently above 60 mL/min/1.73 m² (most recent 92 and 87), do I need any changes to my treatment or further evaluation for renal involvement?
How do I establish a pediatric neurogenic bladder clinic?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.